Market Insights Health Pharmacies OTC Products

Sleep Aids (Pharmacies) - Spain

Spain

Revenue in the Sleep Aids market is projected to reach €160.20m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.37%, resulting in a market volume of €189.10m by 2029.
In global comparison, most revenue will be generated in the United States (€1,366.00m in 2024).
In relation to total population figures, per person revenues of €3.37 are generated in 2024.

Key regions: United States, Germany, Australia, India, United Kingdom

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The Sleep Aids (Pharmacies) market in Spain has been experiencing steady growth in recent years. Customer preferences for sleep aids have shifted towards natural and non-prescription options, driving the demand for these products. Additionally, local special circumstances and underlying macroeconomic factors have contributed to the development of the market.

Customer preferences: In Spain, customers have shown a growing preference for natural sleep aids over prescription medications. This shift can be attributed to a growing awareness of the potential side effects and dependency risks associated with prescription sleep aids. Customers are now seeking alternative options that are perceived as safer and more sustainable. As a result, sales of natural sleep aids, such as herbal supplements and aromatherapy products, have been on the rise.

Trends in the market: One of the key trends in the Sleep Aids (Pharmacies) market in Spain is the increasing popularity of melatonin supplements. Melatonin is a hormone that regulates sleep-wake cycles, and its supplements have gained traction as a natural sleep aid. The convenience and accessibility of melatonin supplements in pharmacies have contributed to their growing demand. Furthermore, the market has witnessed the introduction of innovative sleep aids, such as wearable devices and smart pillows, which track sleep patterns and provide personalized recommendations for improving sleep quality.

Local special circumstances: Spain has a cultural tradition of siestas, where people take a short nap in the afternoon. This cultural practice may contribute to a higher prevalence of sleep disorders and a greater need for sleep aids. Additionally, Spain is known for its vibrant nightlife and late dining culture, which can disrupt sleep patterns and lead to sleep difficulties. These local special circumstances create a favorable environment for the Sleep Aids (Pharmacies) market in Spain, as individuals seek solutions to improve their sleep quality and manage sleep-related issues.

Underlying macroeconomic factors: The Sleep Aids (Pharmacies) market in Spain is influenced by several underlying macroeconomic factors. The aging population in Spain is a significant driver of market growth, as older individuals are more likely to experience sleep-related problems and seek sleep aids. Furthermore, the increasing prevalence of stress and anxiety in modern society has contributed to a higher demand for sleep aids. Economic factors, such as rising disposable incomes and an overall improvement in living standards, have also played a role in driving the market growth, as individuals are more willing to invest in their well-being and prioritize sleep health. Overall, the Sleep Aids (Pharmacies) market in Spain is developing in response to changing customer preferences, local special circumstances, and underlying macroeconomic factors. The shift towards natural sleep aids, the popularity of melatonin supplements, and the introduction of innovative products reflect the evolving needs and expectations of consumers. As the market continues to grow, there is a potential for further innovation and expansion in the sleep aids industry in Spain.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.